Carle Foundation Hospital
Carle Foundation Hospital was paid $8.32M by Medicaid between Jan 2018 and Feb 2024, across 321 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 39% of everything it billed.
33Billing provider infoCARLE FOUNDATION HOSPITAL
URBANA, IL 61801
URBANA, IL 61801
33aNPI1083736177assigned 04/06/2007
33bProvider typeOccupational Therapist
28Total paid$8.32M
24GClaims507,851
24DCodes billed321
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other Occupational Therapist providers in Illinois
Rank by total paid#3 of 289
Median peer was paid$24K
This provider vs. median342×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 136,351 | $2.17M | |
| 2019 | 269,208 | $4.28M | |
| 2020 | 101,945 | $1.87M | |
| 2021 | 288 | $3K | |
| 2024incomplete | 59 | $872.61 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 39% | 38,591 | 11,129 | $3.22M |
| 97162 | 6.8% | 5,124 | 3,482 | $567K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.7% | 12,402 | 4,072 | $395K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.9% | 4,499 | 2,563 | $322K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.5% | 4,772 | 4,171 | $208K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2.5% | 4,120 | 1,825 | $208K |
| 90732 | 1.7% | 1,468 | 600 | $140K | |
| L4360 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 1.5% | 920 | 682 | $129K |
| 90670 | 1.5% | 9,770 | 5,155 | $127K | |
| 0502F | 1.5% | 3,019 | 1,075 | $125K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 8,094 | 7,294 | $117K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.4% | 2,225 | 2,144 | $114K |
309 more codes
| 90651 | 1.4% | 3,431 | $112K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.3% | 8,099 | $110K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 14,915 | $107K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 1.3% | 247 | $104K |
| 97163 | 1.2% | 898 | $103K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 9,314 | $84K |
| 97161 | <1% | 794 | $83K | |
| 92551 | <1% | 5,153 | $71K | |
| 80053 | Comprehensive metabolic panel | <1% | 21,592 | $66K |
| 90715 | <1% | 4,065 | $64K | |
| 90688 | <1% | 6,940 | $54K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,443 | $46K |
| 87507 | <1% | 214 | $44K | |
| 87081 | <1% | 11,380 | $42K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,637 | $38K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,951 | $37K |
| 90686 | <1% | 4,608 | $33K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,048 | $32K |
| 73610 | <1% | 2,089 | $31K | |
| 90734 | <1% | 2,569 | $29K | |
| 73630 | <1% | 2,768 | $29K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,241 | $28K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 790 | $26K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,112 | $25K |
| 58300 | <1% | 323 | $25K | |
| 87536 | <1% | 525 | $25K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 756 | $23K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 764 | $22K |
| 92523 | <1% | 423 | $22K | |
| 87808 | <1% | 4,150 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,588 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,092 | $21K |
| 90723 | <1% | 7,451 | $19K | |
| 92567 | <1% | 1,455 | $18K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 293 | $18K |
| 86480 | <1% | 563 | $18K | |
| 90633 | <1% | 5,471 | $18K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 848 | $18K |
| 92557 | <1% | 648 | $18K | |
| 73560 | <1% | 1,890 | $17K | |
| 94060 | <1% | 492 | $17K | |
| 17110 | <1% | 268 | $16K | |
| 97166 | <1% | 590 | $16K | |
| 90647 | <1% | 7,172 | $16K | |
| 73110 | <1% | 1,388 | $16K | |
| 87631 | <1% | 199 | $15K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 591 | $15K |
| L3807 | Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 102 | $14K |
| 87522 | Neg quan hep c or qual rna | <1% | 524 | $14K |
| 86481 | <1% | 552 | $14K | |
| 83655 | <1% | 2,112 | $14K | |
| 72110 | <1% | 786 | $14K | |
| 85610 | <1% | 6,605 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,271 | $13K |
| 90710 | <1% | 3,182 | $13K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 677 | $13K |
| 0503F | <1% | 300 | $13K | |
| 73030 | <1% | 1,150 | $13K | |
| 90716 | <1% | 1,918 | $13K | |
| 0500F | <1% | 307 | $12K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 6,545 | $12K |
| 86803 | <1% | 2,236 | $12K | |
| 87186 | <1% | 2,405 | $11K | |
| 92015 | Determination of refractive state | <1% | 1,314 | $11K |
| 74018 | <1% | 1,138 | $11K | |
| 72050 | <1% | 677 | $11K | |
| 90681 | <1% | 4,468 | $11K | |
| 90707 | <1% | 1,878 | $11K | |
| 73502 | <1% | 648 | $10K | |
| 87529 | <1% | 453 | $10K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 791 | $10K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 903 | $10K |
| 73130 | <1% | 1,113 | $10K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 253 | $10K |
| 92579 | <1% | 499 | $10K | |
| 84702 | <1% | 2,447 | $9K | |
| L1820 | Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 156 | $9K |
| 86235 | <1% | 590 | $9K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,267 | $9K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 662 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,637 | $9K |
| 73140 | <1% | 1,088 | $8K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 404 | $8K |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 1,863 | $8K |
| 81002 | <1% | 5,856 | $8K | |
| 72100 | <1% | 611 | $8K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 90 | $8K |
| 73562 | <1% | 703 | $7K | |
| 90696 | <1% | 2,210 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 204 | $7K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,717 | $7K |
| 80061 | Lipid panel | <1% | 7,731 | $7K |
| 82728 | <1% | 5,519 | $7K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 168 | $7K |
| 84466 | <1% | 3,688 | $6K | |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | <1% | 1,801 | $6K |
| 90700 | <1% | 2,284 | $6K | |
| 73080 | <1% | 546 | $6K | |
| 87340 | <1% | 3,035 | $6K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,305 | $6K |
| 81511 | <1% | 231 | $6K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 4,324 | $6K |
| 83516 | <1% | 1,493 | $6K | |
| 88720 | <1% | 2,003 | $5K | |
| 86038 | <1% | 1,533 | $5K | |
| 81025 | <1% | 4,977 | $5K | |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | <1% | 152 | $5K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 458 | $5K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,208 | $5K |
| 90662 | <1% | 98 | $5K | |
| 98926 | <1% | 270 | $5K | |
| 82784 | <1% | 1,227 | $5K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,079 | $4K |
| 92134 | <1% | 250 | $4K | |
| 20552 | <1% | 196 | $4K | |
| 84439 | <1% | 4,784 | $4K | |
| 85027 | <1% | 3,576 | $4K | |
| 82607 | <1% | 1,591 | $4K | |
| 87088 | <1% | 954 | $4K | |
| 83001 | <1% | 651 | $4K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 241 | $4K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 169 | $4K |
| 82105 | <1% | 547 | $4K | |
| 83970 | <1% | 277 | $4K | |
| 84403 | <1% | 649 | $4K | |
| 80305 | <1% | 552 | $4K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 69 | $4K |
| 83520 | <1% | 353 | $4K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 412 | $4K |
| 86200 | <1% | 1,011 | $4K | |
| 86003 | <1% | 541 | $4K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 65 | $3K |
| 97165 | <1% | 196 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 769 | $3K |
| 86160 | <1% | 1,024 | $3K | |
| 80074 | <1% | 277 | $3K | |
| 97167 | <1% | 77 | $3K | |
| 95117 | <1% | 878 | $3K | |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 105 | $3K |
| G0008 | Administration of influenza virus vaccine | <1% | 1,627 | $3K |
| 87070 | <1% | 1,458 | $3K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 19 | $3K |
| 84410 | <1% | 202 | $3K | |
| 99173 | <1% | 664 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 96 | $3K |
| 84112 | <1% | 87 | $3K | |
| 92083 | <1% | 92 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 848 | $2K |
| 73590 | <1% | 232 | $2K | |
| 81001 | <1% | 4,892 | $2K | |
| 82570 | <1% | 3,439 | $2K | |
| 94010 | <1% | 74 | $2K | |
| 87338 | <1% | 212 | $2K | |
| 86140 | <1% | 3,755 | $2K | |
| 87905 | <1% | 3,516 | $2K | |
| A4565 | Slings | <1% | 328 | $2K |
| 86592 | <1% | 4,486 | $2K | |
| 83880 | <1% | 361 | $2K | |
| 90636 | <1% | 26 | $2K | |
| 80069 | <1% | 708 | $2K | |
| 96118 | <1% | 28 | $2K | |
| 80164 | <1% | 543 | $2K | |
| 80076 | <1% | 847 | $2K | |
| 69210 | <1% | 98 | $2K | |
| 83020 | <1% | 565 | $2K | |
| 83540 | <1% | 3,916 | $2K | |
| 86696 | <1% | 610 | $2K | |
| 96040 | <1% | 41 | $2K | |
| 86901 | <1% | 1,791 | $2K | |
| 86850 | <1% | 1,650 | $2K | |
| 90746 | <1% | 32 | $1K | |
| 86762 | <1% | 1,285 | $1K | |
| 82950 | <1% | 2,353 | $1K | |
| 83735 | <1% | 1,922 | $1K | |
| 87077 | <1% | 705 | $1K | |
| 73090 | <1% | 163 | $1K | |
| 80055 | <1% | 132 | $1K | |
| L1836 | Knee orthosis, rigid, without joint(s), includes soft interface material, prefabricated, off-the-shelf | <1% | 12 | $1K |
| 86787 | <1% | 319 | $1K | |
| 86706 | <1% | 654 | $1K | |
| 84146 | <1% | 620 | $1K | |
| 86141 | <1% | 226 | $1K | |
| 83993 | <1% | 228 | $1K | |
| 96133 | <1% | 16 | $1K | |
| 77065 | Tomosynthesis, mammo | <1% | 21 | $1K |
| 86147 | <1% | 186 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 30 | $1K |
| 72082 | <1% | 48 | $1K | |
| 86225 | <1% | 517 | $1K | |
| 86580 | <1% | 329 | $1K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 364 | $1K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 687 | $1K |
| 73660 | <1% | 121 | $1K | |
| 85730 | <1% | 761 | $991.06 | |
| 92610 | <1% | 34 | $990.39 | |
| 85379 | <1% | 364 | $963.70 | |
| 92550 | <1% | 78 | $944.74 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 475 | $925.44 |
| 96111 | <1% | 57 | $862.83 | |
| 86704 | <1% | 346 | $832.76 | |
| 73564 | <1% | 57 | $820.84 | |
| 82043 | <1% | 2,513 | $776.94 | |
| 86900 | <1% | 1,797 | $753.53 | |
| 92555 | <1% | 53 | $750.29 | |
| 85652 | <1% | 3,316 | $738.25 | |
| 86431 | <1% | 1,006 | $722.63 | |
| 82951 | <1% | 142 | $704.95 | |
| L3260 | Surgical boot/shoe, each | <1% | 49 | $672.12 |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 13 | $660.25 |
| 87493 | <1% | 29 | $647.04 | |
| 92582 | <1% | 30 | $646.74 | |
| 96132 | <1% | 44 | $636.92 | |
| 92060 | <1% | 50 | $613.75 | |
| 83615 | <1% | 1,112 | $606.09 | |
| 86376 | <1% | 562 | $592.95 | |
| 86360 | <1% | 586 | $585.54 | |
| 87210 | <1% | 2,229 | $580.08 | |
| 87205 | <1% | 1,249 | $562.21 | |
| 86695 | <1% | 634 | $552.01 | |
| 86769 | <1% | 17 | $532.89 | |
| 83883 | <1% | 171 | $528.32 | |
| 82533 | <1% | 76 | $522.40 | |
| Q0112 | All potassium hydroxide (koh) preparations | <1% | 464 | $520.08 |
| 84550 | <1% | 1,224 | $504.12 | |
| 83690 | <1% | 649 | $487.95 | |
| 82962 | <1% | 540 | $483.39 | |
| 90461 | <1% | 148 | $480.85 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 110 | $430.35 |
| 73120 | <1% | 52 | $430.29 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 291 | $414.57 |
| 84481 | <1% | 414 | $379.60 | |
| 82550 | <1% | 497 | $353.28 | |
| 81003 | <1% | 615 | $352.55 | |
| 83021 | <1% | 70 | $350.79 | |
| 86708 | <1% | 356 | $334.30 | |
| J3490 | Unclassified drugs | <1% | 85 | $325.07 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 37 | $321.05 |
| 90713 | <1% | 89 | $312.18 | |
| 91200 | <1% | 29 | $309.15 | |
| 83986 | <1% | 450 | $307.54 | |
| 82746 | <1% | 288 | $306.89 | |
| 84480 | <1% | 286 | $299.00 | |
| 84446 | <1% | 75 | $297.46 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 73 | $297.02 |
| 88304 | <1% | 13 | $254.37 | |
| 82670 | <1% | 230 | $246.67 | |
| 86618 | <1% | 13 | $245.64 | |
| 82274 | <1% | 31 | $245.20 | |
| 86359 | <1% | 553 | $238.28 | |
| 84402 | <1% | 263 | $237.13 | |
| 84156 | <1% | 1,078 | $235.71 | |
| 84153 | <1% | 44 | $224.75 | |
| 84144 | <1% | 60 | $219.90 | |
| 86765 | <1% | 74 | $215.46 | |
| 72072 | <1% | 29 | $214.16 | |
| 85018 | <1% | 695 | $203.61 | |
| 92133 | <1% | 16 | $203.10 | |
| 83721 | <1% | 173 | $200.53 | |
| 82565 | <1% | 117 | $190.58 | |
| 85014 | <1% | 602 | $184.34 | |
| 11721 | <1% | 15 | $176.11 | |
| 84100 | <1% | 530 | $174.83 | |
| 84165 | <1% | 73 | $168.63 | |
| 83002 | <1% | 150 | $150.89 | |
| 86308 | <1% | 170 | $145.40 | |
| 81050 | <1% | 196 | $141.17 | |
| 82247 | <1% | 78 | $140.86 | |
| 86304 | <1% | 18 | $126.72 | |
| 84305 | <1% | 20 | $124.73 | |
| 82626 | <1% | 64 | $120.71 | |
| 80178 | <1% | 56 | $113.20 | |
| 84460 | <1% | 211 | $106.59 | |
| 84432 | <1% | 24 | $106.55 | |
| 87075 | <1% | 16 | $102.17 | |
| 99406 | <1% | 20 | $99.33 | |
| 88342 | <1% | 51 | $98.67 | |
| 84134 | <1% | 231 | $97.74 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 134 | $90.92 |
| 86800 | <1% | 90 | $89.86 | |
| 81015 | <1% | 140 | $89.46 | |
| 84590 | <1% | 81 | $88.40 | |
| 90744 | <1% | 26 | $81.33 | |
| 85613 | <1% | 49 | $78.72 | |
| A6448 | Light compression bandage, elastic, knitted/woven, width less than three inches, per yard | <1% | 78 | $67.28 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 756 | $64.72 |
| 82150 | <1% | 13 | $51.89 | |
| 86705 | <1% | 23 | $44.94 | |
| 82952 | <1% | 128 | $42.83 | |
| 84450 | <1% | 151 | $42.37 | |
| 86780 | <1% | 15 | $42.28 | |
| 84478 | <1% | 88 | $38.08 | |
| 86735 | <1% | 15 | $37.08 | |
| 83498 | <1% | 16 | $34.52 | |
| 84597 | <1% | 47 | $31.78 | |
| 82465 | <1% | 127 | $25.48 | |
| 82977 | <1% | 39 | $21.04 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 899 | $16.29 |
| 82248 | <1% | 26 | $14.28 | |
| 83605 | <1% | 29 | $12.93 | |
| 88312 | <1% | 15 | $11.49 | |
| 83789 | <1% | 14 | $6.98 | |
| 85004 | <1% | 36 | $6.60 | |
| 86709 | <1% | 16 | $5.40 | |
| 85660 | <1% | 18 | $4.54 | |
| 82103 | <1% | 25 | $4.31 | |
| 82390 | <1% | 25 | $4.31 | |
| 36416 | <1% | 12 | $4.10 | |
| 84155 | 0% | 21 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEONARD, JAMES (CEO)
| Provider | Location | Paid |
|---|---|---|
| The Carle Foundation Hospital | Champaign, IL | $6.36M |
| The Carle Foundation Hospital | Champaign, IL | $4.77M |
| The Carle Foundation Hospital | Urbana, IL | $2.52M |
| The Carle Foundation Hospital | Danville, IL | $1.29M |
| The Carle Foundation Hospital | Urbana, IL | $830K |
| The Carle Foundation Hospital | Mattoon, IL | $457K |
| The Carle Foundation Hospital | Normal, IL | $4K |
| Carle Health Care Incorporated | Champaign, IL | $681.19 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.